Navigation Links
Promising New Results On The Added Safety Of Using SmokeStik Electronic Cigarettes In The Bid To Quit Smoking

At long last, an electronic cirarette manufacturer has released initial clinical trial results that smokers have been waiting for. SmokeStik® has released pilot study results on the effects of propylene glycol, and the combination of 3 unique smoking cessation interventions.

(PRWEB) January 9, 2010 -- In the summer of 2009 a smoking cessation pilot study was conducted to deliver more understanding to a multi- modal approach to quitting smoking safely and more effectively.

The aim of the pilot study was to examine overall cessation rates after 12 weeks in a multi-modal cessation program as well as test the safety of electronic cigarettes in terms of propylene glycol levels. This pilot represents a major first step in moving forward with a much larger randomised clinical trial testing whether the combination of multiple interventions has a positive effect on smoking cessation rates.

The current study combined 3 unique smoking cessation interventions; Varenicline, cognitive-behavioural group therapy and a SmokeStik® electronic cigarette.

At the end of the program all participants had quit smoking. Qualitative self-report data revealed that all participants found a multi-modal approach helpful in the smoking cessation process, including the use of an electronic cigarette. Smoking a pack a day equals 110,000 hand to mouth repetitions each year. A Smokestik® is a unique electronic cigarette simulation that helps you positively cope with this conditioned behaviour due to the device closely resembling the appearance of a cigarette.

Biological measures including lab tests conducted each month found negative blood levels of propylene glycol, and pre and post pulmonary function testing showed a marked improvement in participants overall lung functioning.

These results do suggest that multi-modal approaches may increase the chances of quitting smoking and that SmokeStik's electronic cigarettes appear safe with respect to the inhalation of propylene glycol. For further information on these trials please visit


Bill Marangos


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. UV LED therapy shows promising results in preventing focal seizures
2. New insights into mushroom-derived drug promising for cancer treatment
3. Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability
4. Promising pharmaceutical agents emerge as sports doping products
5. Pneumonia Drug Promising Against Form of Muscular Dystrophy
6. Health Alliance Announces Promising Nine-Month Results from First Ever Outcome-Based Reimbursement Program for Actonel(R) (risedronate sodium) Tablets
7. Pittsburgh Partners Launch Promising Family-Centered Care Model: Special Focus on Promoting Parental Well-Being and Healthy Child Development
8. Oklahoma scientists discover promising new path for treating traumas
9. Particle Beam Radiation Therapy Promising But Unproven for Treating Cancer
10. Success of National Fundraising Event Critical to Promising Research for Life-Threatening Kidney Disease
11. Program for 3rd EAU North Eastern European Meeting looks promising
Post Your Comments:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)... Ill. and INDIANAPOLIS , ... students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is ... 2016 scholarship winners, announced today online at ... let type 1 diabetes stand in the way of ... has supported the Foundation,s scholarship program since 2012, and ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology: